Gastrointestinal Endoscopy Devices | US | 2016 | Market Analysis
The expansion of device indications and updated treatment and screening guidelines will support growth in several device segments, helping to offset the negative impact of continued hospital consolidation and the shift toward value-based care in the US. As a result, overall, the US GI endoscopy device market will grow moderately through 2024.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for GI endoscopy devices in the US across a 10-year period.
Among the overall US GI endoscopy device market, the Barrett’s esophagus ablation device segment is the fastest growing.
How many Barrett’s esophagus treatments are performed annually and how quickly will procedure volumes grow?
What percentage of Barrett’s esophagus treatments are performed with RF ablation versus cryoablation?
How many EMR procedures are performed for Barrett’s esophagus?
Colonoscopy procedure volumes will be impacted by CRC screening recommendation updates and the availability of alternative tests.
To what extent will colonoscopy procedure volumes be impacted?
What other procedures and markets will be impacted? How so?
There are a number of recently and soon-to-be approved devices in this market.
How will these devices fare and how will they affect other products already on the market?
Which companies are threatened by these devices? Which ones stand to gain?
